France Archives

sanofi biotech acquisition medivation msd

News and Trends 22 Aug 2016

UPDATE: Sanofi defeated in the Race to acquire Medivation

Even more Big Pharma join the fight to acquire the extremely desirable Medivation, a Biotech developing cancer treatments. Now MSD is joining the bandwagon. Things don’t look so good for Sanofi, which already got rebuffed twice. UPDATE (article originally published on 18/8/2016): Pfizer has struck a deal to acquire Medivation for $14Bn (€12.4Bn), according to the Financial Times. This was […]

August 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 22 Aug 2016

Now we can watch DNA Repair itself!

After 2015’s Nobel Prize in chemistry was awarded for advancements in our understanding of DNA repair, a recent Nature report characterises the mechanism in molecular detail. The implications for cancer research are vast. Researchers in Paris, France, and Bristol, England, have leveraged recent advances in microscopy and fluorescent imaging to characterise the entire process of DNA […]

August 22, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 20 Aug 2016

France is loving this Iranian Bioartist’s Microbe-Inspired Installations

Bioartist Golnaz Behrouznia creates gorgeous multimedia installations inspired by microscopic life. Keep an eye out for her work at festivals in Paris and Toulouse this September. Golnaz Behrouznia has always been passionate about natural science, particularly the world seen through a microscope. Through a combination of plastic sculpture, drawing, and installation video, she brings it […]

August 20, 2016 - 2 minutesmins - By Evelyn Warner

gensight biologics ipo euronext gene therapy

News and Trends 21 Jul 2016

UPDATED: French Gene Therapy for Blindness Launches another IPO

Update (21/07/2016): Gensight has successfully completed its IPO, raising €40M. This brings the Biotech’s total market capitalization to near €149M. The option of round oversubscription to €46M is still open. Originally published on 5/7/2016 After canceling its NASDAQ IPO back in April, GenSight is now launching on the Euronext Paris. It wants to raise €40M in total, […]

July 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

pili tolouse white biotechnology twb bioreactor

News and Trends 20 Jul 2016

SynBio Startup moves to Toulouse to scale up its Bacterial Ink Production

Pili is leaving its bio-hacking nest in Paris for the industrial facilities of TWB, Toulouse’s preindustrial demonstrator for industrial Biotech. It will be able to develop pilot-scale production of its first dye – blue… Pili is one of the examples of Biotech innovation coming out of biohacking spaces. The start-up started at La Paillasse (Paris) and went on […]

July 20, 2016 - 2 minutesmins - By Denise Neves Gameiro

poxel euronext paris diabetes type 2 glimins japan

News and Trends 19 Jul 2016

Poxel raises €26.5M to support Phase III trial in Diabetes

Poxel has closed a capital increase on the Euronext Paris, raising €26.5M. The money is intended to fund its plans to tackle the $4Bn Japanese market for Type 2 diabetes. Biotech is tackling diabetes with many different approaches, from new oral drugs to MedTech and cell therapy. In particular, type 2 diabetes (connected to a […]

July 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 14 Jul 2016

Institut Pasteur & Austrian Biotech also join the World Zika Vaccine Plan

Themis is a Vienna-based vaccine developer. Together with the Institut Pasteur, it is now planning to use a measles vaccine construct to develop and start Zika vaccine trials within the next 12 months. Themis has successfully extended its existing license agreement with Institut Pasteur in Paris, which grants the company a broad access to a well-established virus vaccine vector technology. The […]

July 14, 2016 - 3 minutesmins - By Dani Bancroft

pharnext marie tooth disease IPO pharnext

News and Trends 14 Jul 2016

French Biotech that makes Drugs faster and cheaper IPO’s for €31M

Pharnext has successfully completed its IPO on the Euronext Paris exchange, allowing it to move forward with Phase II and III trials for Neurological diseases that include Alzheimer’s. Based in Paris, Pharnext is developing new therapies for neurological conditions, including rare diseases such as Charcot-Marie-Tooth Disease. New partners to join this biotech in the €31M IPO include Galapagos […]

July 14, 2016 - 2 minutesmins - By Dani Bancroft

servier sorrento pd 1 biotech chemo car t cancer

News and Trends 13 Jul 2016

French Pharma licenses California PD-1 Cancer Antibody for €710M

San Diego’s Sorrento Therapeutics has bagged a quarter-billion euro deal with Servier. The French Pharma giant will develop Sorrento’s PD-1 targeting platform – a key checkpoint inhibitor in Immuno-Oncology. Sorrento’s proprietary G-MAB library platform was used to identify and generate STI-A1110, an antibody which targets PD-1, one of the key targets in the rapidly developing immuno-oncology therapy […]

July 13, 2016 - 2 minutesmins - By Dani Bancroft

abbvie ablynx rheumatoid arthritis nanobody

News and Trends 11 Jul 2016

Nanobody Phase II Results for Arthritis: Good but not good enough?

Ablynx has shown that its candidate for Rheumatoid arthritis could work as a monotherapy, but whether they can convince AbbVie to stick to the previous $840M deal is still unclear. Ghent-based Ablynx has hooked several big Pharmas with its Nanobody platform, based on the shorter monoclonal antibodies of llamas. One of these is AbbVie (France), which is […]

July 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 8 Jul 2016

French Startup raised €4M for Gene Therapy to fix specific Types of Blindness

Horama is developing gene therapies for several hereditary retinal dystrophies. It has now raised €4M in its Series A round, which will speed up development of two candidates. Eye disorders are a popular indication for gene therapies, especially after the first gene therapy approvals – uniQure’s Glybera and GSK’s Strimvelis. Some other players in ophthalmologic […]

July 8, 2016 - 2 minutesmins - By Denise Neves Gameiro

zika sanofi niaid army us vaccine biotech

News and Trends 7 Jul 2016

Sanofi and the US Army team up for a Zika Vaccine, but why isn’t everyone else?

Together with the US Walter Reed Army Institute of Research (WRAIR), the French infectious disease specialist, Sanofi Pasteur, hopes to speed up their promising new Zika virus vaccine. With the concerns over the borderline epidemic of the Zika virus, with its mysterious origins and not fully understood pathophysiology, the Biotech and pharmaceutical industries have united globally […]

July 7, 2016 - 4 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

UPDATE: Sanofi defeated in the Race to acquire Medivation

Now we can watch DNA Repair itself!

France is loving this Iranian Bioartist’s Microbe-Inspired Installations

UPDATED: French Gene Therapy for Blindness Launches another IPO

SynBio Startup moves to Toulouse to scale up its Bacterial Ink Production

Poxel raises €26.5M to support Phase III trial in Diabetes

Institut Pasteur & Austrian Biotech also join the World Zika Vaccine Plan

French Biotech that makes Drugs faster and cheaper IPO’s for €31M

French Pharma licenses California PD-1 Cancer Antibody for €710M

Nanobody Phase II Results for Arthritis: Good but not good enough?

French Startup raised €4M for Gene Therapy to fix specific Types of Blindness

Sanofi and the US Army team up for a Zika Vaccine, but why isn’t everyone else?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!